624 related articles for article (PubMed ID: 25911676)
41. At the "junction" of spinal muscular atrophy pathogenesis: the role of neuromuscular junction dysfunction in SMA disease progression.
Goulet BB; Kothary R; Parks RJ
Curr Mol Med; 2013 Aug; 13(7):1160-74. PubMed ID: 23514457
[TBL] [Abstract][Full Text] [Related]
42. Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates.
Meyer K; Ferraiuolo L; Schmelzer L; Braun L; McGovern V; Likhite S; Michels O; Govoni A; Fitzgerald J; Morales P; Foust KD; Mendell JR; Burghes AH; Kaspar BK
Mol Ther; 2015 Mar; 23(3):477-87. PubMed ID: 25358252
[TBL] [Abstract][Full Text] [Related]
43. Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice.
Tsai LK; Tsai MS; Ting CH; Li H
J Mol Med (Berl); 2008 Nov; 86(11):1243-54. PubMed ID: 18649067
[TBL] [Abstract][Full Text] [Related]
44. Motor neuronal repletion of the NMJ organizer, Agrin, modulates the severity of the spinal muscular atrophy disease phenotype in model mice.
Kim JK; Caine C; Awano T; Herbst R; Monani UR
Hum Mol Genet; 2017 Jul; 26(13):2377-2385. PubMed ID: 28379354
[TBL] [Abstract][Full Text] [Related]
45. Tissue-specific models of spinal muscular atrophy confirm a critical role of SMN in motor neurons from embryonic to adult stages.
Laird AS; Mackovski N; Rinkwitz S; Becker TS; Giacomotto J
Hum Mol Genet; 2016 May; 25(9):1728-38. PubMed ID: 26908606
[TBL] [Abstract][Full Text] [Related]
46. Therapy development for spinal muscular atrophy in SMN independent targets.
Tsai LK
Neural Plast; 2012; 2012():456478. PubMed ID: 22701806
[TBL] [Abstract][Full Text] [Related]
47. Selective Neuromuscular Denervation in Taiwanese Severe SMA Mouse Can Be Reversed by Morpholino Antisense Oligonucleotides.
Lin TL; Chen TH; Hsu YY; Cheng YH; Juang BT; Jong YJ
PLoS One; 2016; 11(4):e0154723. PubMed ID: 27124114
[TBL] [Abstract][Full Text] [Related]
48. Effect of genetic background on the phenotype of the Smn2B/- mouse model of spinal muscular atrophy.
Eshraghi M; McFall E; Gibeault S; Kothary R
Hum Mol Genet; 2016 Oct; 25(20):4494-4506. PubMed ID: 28172892
[TBL] [Abstract][Full Text] [Related]
49. Viral mediated knockdown of GATA6 in SMA iPSC-derived astrocytes prevents motor neuron loss and microglial activation.
Allison RL; Welby E; Khayrullina G; Burnett BG; Ebert AD
Glia; 2022 May; 70(5):989-1004. PubMed ID: 35088910
[TBL] [Abstract][Full Text] [Related]
50. Smn deficiency causes neuritogenesis and neurogenesis defects in the retinal neurons of a mouse model of spinal muscular atrophy.
Liu H; Beauvais A; Baker AN; Tsilfidis C; Kothary R
Dev Neurobiol; 2011 Feb; 71(2):153-69. PubMed ID: 20862739
[TBL] [Abstract][Full Text] [Related]
51. A large animal model of spinal muscular atrophy and correction of phenotype.
Duque SI; Arnold WD; Odermatt P; Li X; Porensky PN; Schmelzer L; Meyer K; Kolb SJ; Schümperli D; Kaspar BK; Burghes AH
Ann Neurol; 2015 Mar; 77(3):399-414. PubMed ID: 25516063
[TBL] [Abstract][Full Text] [Related]
52. Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice.
Perera ND; Sheean RK; Crouch PJ; White AR; Horne MK; Turner BJ
Hum Mol Genet; 2016 Sep; 25(18):4080-4093. PubMed ID: 27466204
[TBL] [Abstract][Full Text] [Related]
53. Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophy.
Schmitt LI; David C; Steffen R; Hezel S; Roos A; Schara-Schmidt U; Kleinschnitz C; Leo M; Hagenacker T
Acta Neuropathol; 2023 May; 145(5):611-635. PubMed ID: 36930296
[TBL] [Abstract][Full Text] [Related]
54. Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy.
Xu CC; Denton KR; Wang ZB; Zhang X; Li XJ
Dis Model Mech; 2016 Jan; 9(1):39-49. PubMed ID: 26586529
[TBL] [Abstract][Full Text] [Related]
55. Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model.
Bowerman M; Beauvais A; Anderson CL; Kothary R
Hum Mol Genet; 2010 Apr; 19(8):1468-78. PubMed ID: 20097679
[TBL] [Abstract][Full Text] [Related]
56. Modeling the early phenotype at the neuromuscular junction of spinal muscular atrophy using patient-derived iPSCs.
Yoshida M; Kitaoka S; Egawa N; Yamane M; Ikeda R; Tsukita K; Amano N; Watanabe A; Morimoto M; Takahashi J; Hosoi H; Nakahata T; Inoue H; Saito MK
Stem Cell Reports; 2015 Apr; 4(4):561-8. PubMed ID: 25801509
[TBL] [Abstract][Full Text] [Related]
57. Hyper-SUMOylation of SMN induced by SENP2 deficiency decreases its stability and leads to spinal muscular atrophy-like pathology.
Zhang Y; Chen X; Wang Q; Du C; Lu W; Yuan H; Zhang Z; Li D; Ling X; Ren X; Zhao Y; Su Q; Xing Z; Qin Y; Yang X; Shen Y; Wu H; Qi Y
J Mol Med (Berl); 2021 Dec; 99(12):1797-1813. PubMed ID: 34628513
[TBL] [Abstract][Full Text] [Related]
58. Oligodendrocyte development and CNS myelination are unaffected in a mouse model of severe spinal muscular atrophy.
O'Meara RW; Cummings SE; De Repentigny Y; McFall E; Michalski JP; Deguise MO; Gibeault S; Kothary R
Hum Mol Genet; 2017 Jan; 26(2):282-292. PubMed ID: 28069797
[TBL] [Abstract][Full Text] [Related]
59. Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy.
Martinez TL; Kong L; Wang X; Osborne MA; Crowder ME; Van Meerbeke JP; Xu X; Davis C; Wooley J; Goldhamer DJ; Lutz CM; Rich MM; Sumner CJ
J Neurosci; 2012 Jun; 32(25):8703-15. PubMed ID: 22723710
[TBL] [Abstract][Full Text] [Related]
60. CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis.
Janzen E; Mendoza-Ferreira N; Hosseinibarkooie S; Schneider S; Hupperich K; Tschanz T; Grysko V; Riessland M; Hammerschmidt M; Rigo F; Bennett CF; Kye MJ; Torres-Benito L; Wirth B
Brain; 2018 Aug; 141(8):2343-2361. PubMed ID: 29961886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
